cilostazol tablet
physicians total care, inc. - cilostazol (unii: n7z035406b) (cilostazol - unii:n7z035406b) - cilostazol 100 mg - cilostazol tablets, usp are indicated for the reduction of symptoms of intermittent claudication, as indicated by an increased walking distance. cilostazol and several of its metabolites are inhibitors of phosphodiesterase iii. several drugs with this pharmacologic effect have caused decreased survival compared to placebo in patients with class iii-iv congestive heart failure. cilostazol tablets, usp are contraindicated in patients with congestive heart failure of any severity. cilostazol tablets, usp are contraindicated in patients with haemostatic disorders or active pathologic bleeding, such as bleeding peptic ulcer and intracranial bleeding. cilostazol tablets, usp inhibit platelet aggregation in a reversible manner. cilostazol tablets, usp are contraindicated in patients with known or suspected hypersensitivity to any of its components.
cilostazol tablet
carilion materials management - cilostazol (unii: n7z035406b) (cilostazol - unii:n7z035406b) - cilostazol 100 mg - cilostazol tablets are indicated for the reduction of symptoms of intermittent claudication, as demonstrated by an increased walking distance. cilostazol is contraindicated in patients with: hypersensitivity to cilostazol or any components of cilostazol (e.g., anaphylaxis, angioedema). teratogenic effects: pregnancy category c . cilostazol has been shown to be teratogenic in rats at doses that are greater than 5-times the human mrhd on a body surface area basis. there are no adequate and well-controlled studies in pregnant women. in a rat developmental toxicity study, oral administration of 1000 mg cilostazol/kg/day was associated with decreased fetal weights, and increased incidences of cardiovascular, renal, and skeletal anomalies (ventricular septal, aortic arch and subclavian artery abnormalities, renal pelvic dilation, 14th rib, and retarded ossification). at this dose, systemic exposure to unbound cilostazol in nonpregnant rats was about 5 times the exposure in humans given the mrhd. increased inciden
xylometazolinehydrochloride 1 mg/ml conserveermiddelvrije neusspray samenwerkende apothekers, neusspray, oplossing
samenwerkende apothekers nederland b.v. kralingseweg 201 3062 ce rotterdam - xylometazolinehydrochloride samenstelling overeenkomend met ; xylometazoline - neusspray, oplossing - citroenzuur 1-water (e 330) ; glycerol 85 per cent (e 422) ; trinatriumcitraat 2-water (e 331) ; water voor injectie - xylometazoline
xylometazoline eg 100 mg/100 ml nasenspray, lösung
eurogenerics afgekort "e.g." - xylometazoline hydrochloride - nasenspray, lösung - 100 mg/100 ml - xylometazoline hydrochloride 1 mg/ml - xylometazoline
xylometazoline hcl neusdruppels apotex 0,5 mg/ml, neusdruppels, oplossing
apotex europe bv archimedesweg 2 2333 cn leiden - xylometazolinehydrochloride samenstelling overeenkomend met ; xylometazoline - neusdruppels, oplossing - benzalkoniumchloride ; dinatriumedetaat 2-water ; dinatriumwaterstoffosfaat 12-water (e 339) ; natriumchloride ; natriumdiwaterstoffosfaat 2-water (e 339) ; water, gezuiverd, - xylometazoline
xylometazoline hcl neusdruppels apotex 1 mg/ml, neusdruppels, oplossing
apotex europe bv archimedesweg 2 2333 cn leiden - xylometazolinehydrochloride samenstelling overeenkomend met ; xylometazoline - neusdruppels, oplossing - benzalkoniumchloride ; dinatriumedetaat 2-water ; dinatriumwaterstoffosfaat 12-water (e 339) ; natriumchloride ; natriumdiwaterstoffosfaat 2-water (e 339) ; water, gezuiverd, - xylometazoline
xylometazoline hcl neusspray apotex 0,5 mg/ml, neusspray, oplossing
apotex europe bv archimedesweg 2 2333 cn leiden - xylometazolinehydrochloride samenstelling overeenkomend met ; xylometazoline - neusspray, oplossing - benzalkoniumchloride ; dinatriumedetaat 2-water ; dinatriumwaterstoffosfaat 12-water (e 339) ; dinatriumwaterstoffosfaat 2-water (e 339) ; natriumchloride ; water, gezuiverd, - xylometazoline
xylometazoline hcl neusspray apotex 1,0 mg/ml, neusspray, oplossing
apotex europe bv archimedesweg 2 2333 cn leiden - xylometazolinehydrochloride samenstelling overeenkomend met ; xylometazoline - neusspray, oplossing - benzalkoniumchloride ; dinatriumedetaat 2-water ; dinatriumwaterstoffosfaat 12-water (e 339) ; natriumchloride ; natriumdiwaterstoffosfaat 2-water (e 339) ; water, gezuiverd, - xylometazoline
xylometazolinehydrochloride 1 mg/ml neusspray samenwerkende apothekers, neusspray oplossing
samenwerkende apothekers nederland b.v. kralingseweg 201 3062 ce rotterdam - xylometazolinehydrochloride samenstelling overeenkomend met ; xylometazoline - neusspray, oplossing - benzalkoniumchloride ; dinatriumedetaat 2-water ; dinatriumwaterstoffosfaat 12-water (e 339) ; natriumchloride ; natriumdiwaterstoffosfaat 2-water (e 339) ; water, gezuiverd, - xylometazoline
xylometazoline hcl sanias 0,5 mg/ml, neusdruppels, oplossing
aurobindo pharma b.v. baarnsche dijk 1 3741 ln baarn - xylometazolinehydrochloride 0,5 mg/ml samenstelling overeenkomend met ; xylometazoline 0,43 mg/ml - neusdruppels, oplossing - benzalkoniumchloride ; dinatriumedetaat 2-water ; dinatriumwaterstoffosfaat 12-water (e 339) ; natriumchloride ; natriumdiwaterstoffosfaat 2-water (e 339) ; water, gezuiverd, - xylometazoline